Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox endoscopic injection for adolescent obesity
2016-000326-19Phase 2Completed
- Sponsor
- St. Olavs University Hospital
- Start
- Apr 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of botulinum toxin type A in obesity (3 arms), sponsored by St. Olavs University Hospital. Primary endpoint: Body weight (ISO-BMI). Started Apr 2016; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
obesity
Beyond the preview
Go deeper on 2016-000326-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000326-19.